Keywords: mgi, hit, hard, cancer, drug, trial, stopped

MGI hit hard as cancer drug trial is stopped

Article | 22 April 2002

Print This

MGI Pharma of the USA saw more than 40% of the value of its shares wipedout after announcing that irofulven, its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in